Indication

Staphylococcal pneumonia

Staphylococcal pneumonia is an acute, severe lower respiratory tract infection primarily caused by *Staphylococcus aureus*, involving either methicillin-susceptible or methicillin-resistant strains. Read more about Staphylococcal pneumonia

495 drugs 150 manufacturers

Advertisement

Drugs that treat it

Common Staphylococcal pneumonia therapies.

Showing 190–198 of 495 drugs

VANCOMYCIN HCL

VANCOMYCIN INTRAVENOUS·CLOSTRIDIOIDES DIFFICILE INFECTION·+18
APP/PREMIERPRO
Filter & compare in the drug finder →Opens the drug finder with Staphylococcal pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Staphylococcal pneumonia.

Staphylococcal pneumonia is an acute, severe lower respiratory tract infection primarily caused by *Staphylococcus aureus*, involving either methicillin-susceptible or methicillin-resistant strains.

It affects pediatric, elderly, and immunocompromised individuals in community settings—frequently manifesting as a secondary infection following viral respiratory illnesses such as influenza—as well as hospitalized and mechanically ventilated patients.

Pathophysiologically, bacterial virulence factors, including cytotoxins and tissue-destructive enzymes, drive intense alveolar inflammation that can rapidly progress to tissue necrosis.

Clinically, it presents with high fever, cough, dyspnea, and purulent sputum, and it carries a high risk of aggressive complications such as cavitary or necrotizing pneumonia, pneumatoceles, empyema, and rapid deterioration into septic shock.

Personalize your experience

Follow Staphylococcal pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it